{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:58:32Z","timestamp":1792897112713,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clnu.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T10:43:02Z","timestamp":1612694582000},"page":"4106-4112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS"],"prefix":"10.1016","volume":"40","author":[{"given":"Asieh","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Sanginabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadis","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin","family":"Shirzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armita","family":"Mahdavi-Gorabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Mohajeri-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Qorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib1","first-page":"55","article-title":"Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study","volume":"11","author":"Rencber","year":"2018","journal-title":"J\u00a0Ovarian Res"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/1472-6882-14-511","article-title":"Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo\/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings","volume":"14","author":"Arentz","year":"2014","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.clnu.2021.02.004_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel","year":"2018","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clnu.2021.02.004_bib4","first-page":"551","article-title":"Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome","volume":"15","author":"Mansour","year":"2016","journal-title":"EXCLI journal"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/nyas.12875","article-title":"Ovarian actions of resveratrol","volume":"1348","author":"Ortega","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.clnu.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/molehr\/gaq002","article-title":"Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells","volume":"16","author":"Wong","year":"2010","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib7","first-page":"21","article-title":"Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis","volume":"7","author":"Ortega","year":"2014","journal-title":"J\u00a0Ovarian Res"},{"issue":"11","key":"10.1016\/j.clnu.2021.02.004_bib8","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1210\/jc.2016-1858","article-title":"Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial","volume":"101","author":"Banaszewska","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2021.02.004_bib9","first-page":"1","article-title":"Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial","author":"Bahramrezaie","year":"2019","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Group Reaspcw","year":"2004","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5001\/omj.2012.112","article-title":"Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism","volume":"27","author":"Al Kindi","year":"2012","journal-title":"Oman Med J"},{"key":"10.1016\/j.clnu.2021.02.004_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fendo.2018.00452","article-title":"Androgen action in the ovary","volume":"9","author":"Franks","year":"2018","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.004_bib13","first-page":"5410","article-title":"Analysis of the efficacy of resveratrol treatment in patients with scarred uterus","volume":"15","author":"Ma","year":"2018","journal-title":"Experimental and therapeutic medicine"},{"key":"10.1016\/j.clnu.2021.02.004_bib14","article-title":"Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic ovary syndrome","volume":"2013","author":"Benrick","year":"2013","journal-title":"Evid base Compl Alternative Med"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib15","first-page":"113","article-title":"Effects of flaxseeds supplementation in polycystic ovarian syndrome","volume":"31","author":"Farzana","year":"2015","journal-title":"Int J Pharmaceut Sci Rev Res"},{"issue":"440","key":"10.1016\/j.clnu.2021.02.004_bib16","first-page":"2","article-title":"Epidemiological assessment of testosterone levels in women population: a factorial analysis of cell proliferation","volume":"10","author":"Okpashi","year":"2018","journal-title":"Biol Med"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1530\/EC-12-0057","article-title":"Inverse association between serum insulin and sex hormone-binding globulin in a population survey in Sweden","volume":"2","author":"Daka","year":"2013","journal-title":"Endocrine connections"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2042018810367984","article-title":"Evidence for statin therapy in polycystic ovary syndrome","volume":"1","author":"Sathyapalan","year":"2010","journal-title":"Therapeutic advances in endocrinology and metabolism"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.fertnstert.2012.08.004","article-title":"Effects of resveratrol on growth and function of rat ovarian granulosa cells","volume":"98","author":"Ortega","year":"2012","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.clnu.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1210\/en.2012-1385","article-title":"Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt\/PKB signaling pathway","volume":"153","author":"Ortega","year":"2012","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.clnu.2021.02.004_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/eem.11.85","article-title":"Androgens and polycystic ovary syndrome","volume":"7","author":"Alpa\u00f1\u00e9s","year":"2012","journal-title":"Expet Rev Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib23","first-page":"64","article-title":"5\u03b1-Reductase inhibitory compounds produced by polymerization of resveratrol with horseradish peroxidase","volume":"48","author":"Hirano","year":"2002","journal-title":"J\u00a0Wood Sci"},{"issue":"14","key":"10.1016\/j.clnu.2021.02.004_bib24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2174\/138945012804545579","article-title":"Androgen receptor in human health: a potential therapeutic target","volume":"13","author":"Rahman Siddique","year":"2012","journal-title":"Curr Drug Targets"},{"issue":"2","key":"10.1016\/j.clnu.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1933719117711262","article-title":"Melatonin treatment may be able to restore menstrual cyclicity in women with PCOS: a pilot study","volume":"25","author":"Tagliaferri","year":"2018","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.clnu.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/obr.12775","article-title":"Resveratrol supplementation significantly influences obesity measures: a systematic review and dose\u2013response meta-analysis of randomized controlled trials","volume":"20","author":"Mousavi","year":"2019","journal-title":"Obes Rev"},{"issue":"7","key":"10.1016\/j.clnu.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/met.2016.0035","article-title":"The effects of resveratrol supplementation in overweight and obese humans: a systematic review of randomized trials","volume":"14","author":"Christenson","year":"2016","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"10.1016\/j.clnu.2021.02.004_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/db12-0975","article-title":"High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition","volume":"62","author":"Poulsen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuroimage.2018.03.023","article-title":"Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults\u2013A randomized controlled trial","volume":"174","author":"Huhn","year":"2018","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.clnu.2021.02.004_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/nu8020073","article-title":"Resveratrol supplementation in schizophrenia patients: a randomized clinical trial evaluating serum glucose and cardiovascular risk factors","volume":"8","author":"Zortea","year":"2016","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.004_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12986-017-0217-z","article-title":"Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis","volume":"14","author":"Zhu","year":"2017","journal-title":"Nutr Metab"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.004_bib32","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil steril"},{"issue":"4","key":"10.1016\/j.clnu.2021.02.004_bib33","first-page":"128","article-title":"Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes","volume":"2","author":"Bermudez","year":"2007","journal-title":"Revista Latinoamericana de Hipertensi\u00f3n"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421000789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421000789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:03:25Z","timestamp":1759367005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561421000789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0261561421000789"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2021.02.004","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}